Tian Tian

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial

Constantine S. Tam, Jennifer R. Brown, Brad S. Kahl et al. · The Lancet Oncology · 2022 · 256 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Zanubrutinib Versus Bendamustine +10

Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study

Linghui Zhou, Yujiao Deng, Na Li et al. · Journal of Hematology & Oncology · 2019 · 189 citations · Full text

Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies

Wensen Chen, Sumin Wang, Tian Tian et al. · European Journal of Human Genetics · 2009 · 109 citations · Full text

Metabolic Syndrome, Cancer Risk, Growth Hormone +11

Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma

Nur Rahadiani, Jun Ikeda, Tomoki Makino et al. · Annals of Surgical Oncology · 2010 · 69 citations

Tumor Biology, Esophageal Cancer, Pathology +4

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers

Miao Ruan, Tian Tian, Jia Rao et al. · Diagnostic Pathology · 2018 · 47 citations · Full text